Blood Preparation Market Size To Grow USD 81.99 Billion by 2032

According to a recent research report titled “Blood Preparation Market (By Product: Whole blood, Blood components, Blood derivatives; By Antithrombotic and Anticoagulants Type: Platelet aggregation inhibitors, Fibrinolytics, Anticoagulants; By Application: Thrombocytosis, Renal impairment, Pulmonary embolism, Angina blood vessel complications, Others; By End User: Clinics, Hospitals, Diagnostic centers, Research labs, Blood banks) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032″ published by Precedence Research, the global blood preparation market size is projected to touch around USD 81.99 billion by 2032 and growing at a CAGR of 6% over the forecast period 2023 to 2032. This comprehensive study examines various factors and their impact on the growth of the blood preparation market.

Key Takeaways

• North America contributed more than 45% of revenue share in 2022.
• Asia Pacific is expected to witness the fastest growth rate in the blood preparation market during the forecast period.
• By product, the whole blood segment held the largest share of the blood preparation market in 2022.
• The blood derivatives segment is expected to grow at a significant compounded annual growth (CAGR) rate during the forecast period.
• By application, the thrombocytosis segment accounted for a larger share in 2022.
• The angina blood vessel complications segment is estimated to grow with a notable CAGR during the study period till 2032.

The report primarily focuses on the volume and value of the blood preparation market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.

Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3551

The research also highlights significant progressions in both organic and inorganic growth strategies within the global blood preparation market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the blood preparation market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.

Blood Preparation Market Scope

Also read: Molecular Biology Enzymes Market Size to Record US$ 58.83 billion by 2032

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.

Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

Market Key Players

The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the blood preparation market.

Blood Preparation Market Players

• AstraZeneca plc
• Baxter International Inc
• Bristol-Myers Squibb Company
• Celgene Corp.
• GlaxoSmithKline PLC
• Leo Pharma A/S
• Pfizer, Inc.
• Portola Pharmaceuticals, Inc.
• Sanofi
• Shandong East Chemical Industry Co.
• Xiamen Hisunny Chemical Co., LTD

Segments Covered in the Report

By Product

• Whole blood
  • Granulocytes
  • Red blood cells
  • Plasma
  • Platelets
• Blood components
  • Leukocyte reduced red blood cells
  • Packed red blood cells
  • Frozen plasma
  • Platelet concentrates
  • Cryoprecipitate
• Blood derivatives

By Antithrombotic and Anticoagulants Type

• Platelet aggregation inhibitors
  • Glycoprotein inhibitors
  • ADP antagonists
  • COX inhibitors
  • Others
• Fibrinolytics
  • Streptokinase
  • Tissue plasminogen activator (tPA)
  • Urokinase
• Anticoagulants
  • Heparins
    • Low molecular weight heparin (LMWH)
    • Unfractionated heparin
    • Ultra-low molecular weight heparin
  • Direct thrombin inhibitors
  • Vitamin K antagonists
  • Direct factor Xa inhibitors

By Application

• Thrombocytosis
• Renal impairment
• Pulmonary embolism
• Angina blood vessel complications
• Others

By End User

• Clinics
• Hospitals
• Diagnostic centers
• Research labs
• Blood banks

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Table of Content:

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood Preparation Market 

5.1. COVID-19 Landscape: Blood Preparation Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood Preparation Market, By Product

8.1. Blood Preparation Market Revenue and Volume Forecast, by Product, 2023-2032

8.1.1. Whole blood

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Blood components

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Blood derivatives

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Blood Preparation Market, By Antithrombotic and Anticoagulants Type

9.1. Blood Preparation Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type, 2023-2032

9.1.1. Platelet aggregation inhibitors

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Fibrinolytics

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Anticoagulants

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Blood Preparation Market, By Application 

10.1. Blood Preparation Market Revenue and Volume Forecast, by Application, 2023-2032

10.1.1. Thrombocytosis

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Renal impairment

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Pulmonary embolism

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

10.1.4. Angina blood vessel complications

10.1.4.1. Market Revenue and Volume Forecast (2020-2032)

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Blood Preparation Market, By End User 

11.1. Blood Preparation Market Revenue and Volume Forecast, by End User, 2023-2032

11.1.1. Clinics

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Hospitals

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Diagnostic centers

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

11.1.4. Research labs

11.1.4.1. Market Revenue and Volume Forecast (2020-2032)

11.1.5. Blood banks

11.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Blood Preparation Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Antithrombotic and Anticoagulants Type (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

Chapter 13. Company Profiles

13.1. AstraZeneca plc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Baxter International Inc

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Bristol-Myers Squibb Company

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Celgene Corp.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. GlaxoSmithKline PLC

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Leo Pharma A/S

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Pfizer, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Portola Pharmaceuticals, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Sanofi

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Shandong East Chemical Industry Co.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Why should you invest in this report?

This report presents a compelling investment opportunity for those interested in the global blood preparation market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for blood preparation. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.

Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.

Some of the key questions answered in this report:       

• What is the size of the overall Blood preparation market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the Blood preparation market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Blood preparation market?
• What is the Blood preparation market size at the regional and country-level?
• Who are the key market players and their key competitors?
• What are the strategies for growth adopted by the key players in Blood preparation market?
• What are the recent trends in Blood preparation market? (M&A, partnerships, new product developments, expansions)?
• What are the challenges to the Blood preparation market growth?
• What are the key market trends impacting the growth of Blood preparation market?

 

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

---